Edouard Daher, MD
Cardiovascular Disease · Saint Clair Shores, MINPI 1770515504
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,535 of the $16,156 with a category attached, or 83.8%. 35 manufacturers reported payments, led by Medtronic at 24.0% of the total. 2025 is the largest year on record at $6,519, 2.4 times the $2,754 reported in 2019.
Across 233 payments — averaging $69.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$4K
- Boston Scientific$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$924
- Teleflex LLC$836
- Inari Medical, Inc.$796
- plus $4K from 29 others
Across 22 payments — averaging $3903.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genetesis, Inc.$60K
- Abbott$26K
What the payments were for
- Travel & lodging$2,60216%
- Food & beverage$13,53584%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 33 | $3,882 |
| Abbott | 45 | $3,582 |
| Boston Scientific | 18 | $1,987 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 21 | $924 |
| Teleflex LLC | 11 | $836 |
| Inari Medical, Inc. | 6 | $796 |
| Abiomed | 5 | $559 |
| Amgen | 14 | $528 |
| Cardiva Medical, Inc. | 3 | $261 |
| Cardiovascular Systems Inc. | 3 | $249 |
| Novartis | 15 | $246 |
| Recor Medical Inc | 3 | $243 |
| Pfizer | 9 | $216 |
| Boehringer Ingelheim | 5 | $193 |
| Stryker | 1 | $188 |
| Actelion Pharmaceuticals US, Inc. | 3 | $181 |
| Siemens Medical Solutions USA, Inc. | 1 | $148 |
| Shockwave Medical, Inc | 1 | $147 |
| Penumbra, Inc. | 1 | $146 |
| E.r. Squibb & Sons, L.L.C. | 9 | $145 |
| Ablative Solutions, Inc. | 1 | $110 |
| Impulse Dynamics (USA) Inc. | 1 | $93 |
| Kestra Medical Technology Services, Inc. | 3 | $91 |
| Johnson & Johnson | 5 | $70 |
| Merck | 3 | $68 |
| Philips North America LLC | 1 | $56 |
| Novo Nordisk | 2 | $38 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| AstraZeneca | 2 | $24 |
| Angiodynamics, Inc. | 1 | $24 |
| Avinger Inc. | 1 | $24 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $23 |
| Terumo Medical Corporation | 1 | $20 |
| EKOS Corporation | 1 | $14 |
| Cardinal Health 200 LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$966
- CT THROMBECTOMY SYSTEM KIT$966
- GENERAL - THERAPIES$840
- Optis Coronary Imaging System$590
- Impella$508
- Xience Sierra Coronary Stent System$365
- PRESSUREWIRE$307
- GUIDELINER$291
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$283
- CardioMEMS HF System$265
- Repatha$251
- WATCHMAN FLX$250
- TURNPIKE$239
- PARADISE RENAL DENERVATION SYSTEM$170
- HeartMate 3 Left Ventricular Dev$164
- OPTIS$154
- COREVALVE EVOLUT R$151
- COROFLOW$149
- CorPath Imaging System$148
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$147
How this compares
$16,156 in reported general payments places this provider in the 80th percentile of 760 cardiovascular disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 256 | $338,539 |
| XareltoRivaroxaban | 134 | $158,793 |
| EntrestoSacubitril/Valsartan | 71 | $104,975 |
| JardianceEmpagliflozin | 39 | $52,152 |
| Metoprolol Succinate | 491 | $10,610 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 194 | $5,147 |
| Losartan Potassium | 374 | $4,976 |
| Atorvastatin Calcium | 310 | $4,604 |
| Ranolazine ErRanolazine | 43 | $4,252 |
| Rosuvastatin Calcium | 173 | $3,527 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 66 | $2,661 |
| ClopidogrelClopidogrel Bisulfate | 130 | $2,631 |
| Cilostazol | 75 | $2,562 |
| Hydralazine Hcl | 113 | $2,530 |
| Metoprolol Tartrate | 304 | $2,487 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $216 | $338,539256 claims |
| Johnson & JohnsonXarelto | $70 | $158,793134 claims |
| NovartisEntresto | $246 | $104,97571 claims |
| Boehringer IngelheimJardiance | $193 | $52,15239 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 760 cardiovascular disease providers in Michigan.
Other cardiovascular disease in Saint Clair Shores
- Marschall RungeAnn Arbor$1.8M
- Jihad MustaphaGrand Rapids$1.6M
- Vallerie McLaughlinAnn Arbor$947K
- Pedro Villablanca SpinettoDetroit$620K
- Stanley ChetcutiAnn Arbor$573K
- David HainesRoyal Oak$492K
- Steven AlmanyTroy$471K
- David StroblLansing$445K
- Herman KadoSouthfield$442K
- Douglas HorstmanshofRoyal Oak$407K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.